Nanomedicine News

RSS

FDA Grants Fast Track Designation for Development of TKM-Ebola Viral Therapeutic

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of TKM-Ebola, an anti-Ebola viral therapeutic.

6 Mar 2014

Clinical Data on BIND Therapeutics’ Candidate to be Presented at AACR Annual Meeting 2014

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that three poster presentations including clinical data on its lead drug candidate, BIND-014 and preclinical data on its AstraZeneca collaboration based on Barasertib (AZD1152), will be presented at the upcoming American Association of Cancer Research (AACR) meeting which takes place April 5-9, 2014 in San Diego, CA.

6 Mar 2014

HDL Nanotherapy Directly Targets and Lowers Dangerous Inflammation in Blood Vessels

Nanoparticles designed for drug delivery run the gamut from very artificial components like gold or specially designed RNA to particles that adapt or mimic naturally occurring nanoparticles. A noteworthy example of the latter is adapting biology’s “good cholesterol”, the high-density lipoprotein particle, to deliver anti-inflammatory drugs to prevent recurrent heart attacks and strokes.

6 Mar 2014

Institute for Macromolecular Analysis and Nanomedicine Innovation Symposium Takes Place at NCKU

“Now is really the perfect time in history for the university here in Tainan to jump into the field of cryo-EM (cryo-electron microscopy),” said Dr. Robert M. Glaeser, Professor Emeritus of Biochemistry, Biophysics and Structural Biology, UC Berkeley, USA, at a symposium held at National Cheng Kung University (NCKU), Tainan, Taiwan, March 4th.

6 Mar 2014

Researchers Test Four Iron-Oxide Nanoparticle Systems for Targeting Cancer Cells

In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells.

4 Mar 2014

Happy Accidents Advance Versatility of Polymers for Nanomedicine

One of the most basic tenets of science is observation, an essential tool with the power not only to prevent but also in some cases redefine failure.

4 Mar 2014

U.Va. nanoSTAR Gets Nanotechnology Expert as New Co-Director

Recognizing the potential of microscopic nanotechnology to revolutionize the field of medicine, the University of Virginia has recruited one of the nation’s top experts to serve as co-director of the Institute for Nanoscale and Quantum Scientific and Technological Advanced Research, or nanoSTAR.

3 Mar 2014

Two-Photon Laser Triggers Nanoparticles to Release Chemotherapy Drugs Directly in Tumor Cells

Researchers from UCLA's Jonsson Comprehensive Cancer Center have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength.

From University of California, Los Angeles 28 Feb 2014

Novavax and HHS-BARDA Extend Contract for Development of Recombinant Influenza Vaccines

Novavax, Inc. announced today the execution of a contract modification to extend the base period of performance of its current contract with the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) for the advanced development of Novavax' recombinant seasonal and pandemic influenza vaccines.

From Novavax Inc. 28 Feb 2014

Advances in Using Nanoparticles and Magnetism to Treat Cancer

Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer.

26 Feb 2014

Nanomedicine News

FDA Grants Fast Track Designation for Development of TKM-Ebola Viral Therapeutic

Clinical Data on BIND Therapeutics’ Candidate to be Presented at AACR Annual Meeting 2014

HDL Nanotherapy Directly Targets and Lowers Dangerous Inflammation in Blood Vessels

Institute for Macromolecular Analysis and Nanomedicine Innovation Symposium Takes Place at NCKU

Researchers Test Four Iron-Oxide Nanoparticle Systems for Targeting Cancer Cells

Happy Accidents Advance Versatility of Polymers for Nanomedicine

U.Va. nanoSTAR Gets Nanotechnology Expert as New Co-Director

Two-Photon Laser Triggers Nanoparticles to Release Chemotherapy Drugs Directly in Tumor Cells

Novavax and HHS-BARDA Extend Contract for Development of Recombinant Influenza Vaccines

Advances in Using Nanoparticles and Magnetism to Treat Cancer

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable Future for Carbon Nanotubes

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials